RANCHO CORDOVA, Calif.,
Aug. 6, 2019 /PRNewswire/
-- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market
leader in automated cell processing and autologous cell therapies
for regenerative medicine, today announced that the Company
will release its financial results for the second quarter ended
June 30, 2019 on Tuesday, August 13, 2019 after the close of
trading. A conference call and webcast will follow at
1:30 p.m. PDT/ 4:30 p.m. EDT.
To participate in the conference call, please dial
1-844-889-4331 (domestic), 1-412-380-7406 (international) or
1-866-605-3852 (Canada). To
access a live webcast of the call, please visit:
http://investors.cescatherapeutics.com/events-and-presentations/events.
A replay of the call will be available until September 3 and can be accessed by dialing
1-877-344-7529 (domestic), 1-412-317-0088 (international)
or 1-855-669-9658 (Canada)
and referencing access code 10132960. The webcast will be available
for three months.
About Cesca Therapeutics Inc.
Cesca Therapeutics Inc. is a market leader in cell processing
technologies and autologous cell therapies for regenerative
medicine. Its device division, ThermoGenesis develops,
commercializes and markets a full suite of solutions for automated
clinical biobanking, point-of-care applications, and automation for
immuno-oncology. The Company's automated, functionally-closed
CAR-TXpress™ platform is designed to streamline the manufacturing
process for the emerging CAR-T immunotherapy market. For more
information visit: www.thermogenesis.com and
www.cescatherapeutics.com.
Company Contact:
Wendy
Samford
916-858-5191
ir@thermogenesis.com
Investor Contact:
Paula Schwartz, Rx
Communications
917-322-2216
pschwartz@rxir.com
View original
content:http://www.prnewswire.com/news-releases/cesca-therapeutics-to-announce-financial-results-for-the-second-quarter-ended-june-30-2019-and-host-a-conference-call-on-august-13-300896509.html
SOURCE Cesca Therapeutics Inc.